User: Genecampaign Topic: IP
Category: patent-legal-regime :: india
Last updated: May 09 2018 24:48 IST RSS 2.0
 
1 to 20 of 1,563    
Ensure software standards don't create monopolies: Ravi Shankar Prasad tells IT cos 8.5.2018 DNA: Urban Tales
Law and IT minister Ravi Shankar Prasad today cautioned software companies that norms or standards being worked out by the industry should not create monopolies in the market and instead facilitate digital inclusion and innovation. "Standards .. Should be nuanced in a manner that the ability of standards should not become monopoly of few and exclusion of others. Why I am saying so because open source of software was area of great debate even from international players too. On the garb of close source I would not allow India to become monopoly of few," Prasad said. He was speaking at an event by CNBC-TV18 and The Bureau of Indian Standards (BIS) on standard for softwares. Earlier some of the global firms have attempted that software coding should be granted patents but the same had been opposed by various Indian companies and not-profit entities. "Standard must lay down standard of compliance, standard must lay down to facilitate operation, standard to ensure cost effective operation. Standard should also ...
Also found in: [+]
Economic survey points out child, maternal malnutrition as major risk factors for health 29.1.2018 Sify Finance
Also found in: [+]
Medical association seeks tax breaks for GST and R&D centres from budget 9.1.2018 Sify Finance
Also found in: [+]
Anirudh Singh: Fighting phone-distractions with a patent 30.10.2017 Sify Finance
Also found in: [+]
Corrected: Apple faces down Qualcomm, Ericsson over EU patent fees 2.10.2017 TOI: Intl Business
EU-TECHNOLOGY-PATENTS:Corrected: Apple faces down Qualcomm, Ericsson over EU patent fees
Also found in: [+]
Challenge of Allergan tribal patent deal in uncharted legal territory 15.9.2017 TOI: Intl Business
ALLERGAN-PATENTS/ (CORRECTED):REFILE-Challenge of Allergan tribal patent deal in uncharted legal territory
Also found in: [+]
U.S. tribal patent deal could have big impact on generic drug market 12.9.2017 TOI: Intl Business
ALLERGAN-PATENTS/MOHAWK:U.S. tribal patent deal could have big impact on generic drug market
Also found in: [+]
Victrex: Hits record high on tax rate cut, CEO appointment 4.9.2017 TOI: Intl Business
BUZZ-Victrex: Hits record high on tax rate cut, CEO appointment:BUZZ-Victrex: Hits record high on tax rate cut, CEO appointment
Also found in: [+]
India grants Pfizer patent for pneumonia vaccine; health groups say disease treatment will be out of reach for poor 22.8.2017 DNA: Wide Angle
India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations. The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026. It's a big victory for the U.S. drugmaker in a market that has the world's largest number of pneumonia cases, a lung disease that kills nearly a million children a year globally. The decision also has international implications, as several poorer nations rely on India's robust drugs industry to supply cheaper copies of medicines and vaccines. It also comes at a time of ongoing U.S. pressure on India to tighten its patent laws. The United States Trade Representative expressed concerns about India's intellectual property laws in a report in June, and listed it among countries whose IP laws unfairly favour local companies. Pfizer's vaccine protects ...
Also found in: [+]
Government to ensure protection of film, music IPRs: Nirmala Sitharaman 22.8.2017 ET: Media
Talking about the workshop, Sitharaman said through this exercise the ministry is trying to build awareness about protection of IPRs.
Also found in: [+]
India grants Pfizer patent on pneumonia vaccine in blow to aid group 22.8.2017 TOI: Intl Business
PFIZER-INDIA/VACCINE (UPDATE 1):UPDATE 1-India grants Pfizer patent on pneumonia vaccine in blow to aid group
Also found in: [+]
Arista Networks says International Trade Commission issued notice in connection with investigation no. 337-Ta-944 7.8.2017 TOI: Intl Business
BRIEF-Arista Networks says International Trade Commission issued:BRIEF-Arista Networks says International Trade Commission issued notice in connection with investigation no. 337-Ta-944
Also found in: [+]
Adviser charged with insider trading on Pfizer-King deal pleads guilty 26.7.2017 TOI: Intl Business
USA-INSIDERTRADING/PFIZER:Adviser charged with insider trading on Pfizer-King deal pleads guilty
Also found in: [+]
U.S. Supreme Court ruling leads to offensive trademark requests 23.7.2017 TOI: Intl Business
USA-COURT/SLUR (PIX):U.S. Supreme Court ruling leads to offensive trademark requests
Also found in: [+]
DIPP to set up India’s first TISC in Punjab 13.7.2017 Govt of india: PIB
The Department of Industrial Policy and Promotion (DIPP), Ministry of Commerce & Industry, Government of India, signed an Institutional agreement with the Punjab State Council of Science and Technology in New Delhi
Also found in: [+]
Govt asks NITs to buck up after poor show in ’17 rankings 7.6.2017 ET: Education
The HRD minister has even called for a separate meeting with the NITs who have not done well in NIRF ranking and placement.
Also found in: [+]
Apple, Facebook eye control of digital payments IP in India 30.5.2017 Rediff: Business
Both firms have made several applications for patents pertaining to digital payments in the country
Also found in: [+]
Transfer of IP assets by pharma firms to abroad under RBI scrutiny 29.5.2017 ET: Pharma
Several pharma cos including some of the leading ones have over the years steadily transferred most of their IPs outside India and reduced their tax burden in the country.
Also found in: [+]
Roche vs Indian Pharma: The battle for a cheaper cancer drug 14.5.2017 ET: Pharma
The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first woman pharma-billionaire, Kiran Mazumdar-Shaw.
Also found in: [+]
'India's IPR policy a good first step, needs to address gaps' 13.5.2017 ET: Policy
Both, the companies in the United States and the Trump administration have been expressing concerns over some aspects of the Indian IPR policy.
Also found in: [+]
1 to 20 of 1,563